COVID-19: Ireland suspends AstraZeneca vaccine over clotting concerns

Ireland has temporarily halted its use of the Oxford/AstraZeneca coronavirus vaccine after some reports of blood clots. The move came after a review from the Norwegian Medicines Agency showed four new cases of 'serious blood clotting in adults' had occurred after the jab, despite the World Health Organisation having sought to downplay concerns and urge countries to keep using it. The vaccine will continue to be administered in Northern Ireland, however, after the country's health body sought advice from the UK's medicine regulator.